Product Information

DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY is a generic product labeled by Cipla USA Inc., priced at $29.3540 per ML under NDC 69097050327. Its NADAC has been published 329 times since Jul 29, 2020.

FDA first approved this application on May 20, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY

Dihydroergotamine Mesylate Nasal
$29.3540per ML

Strength

4 mg/mL

Manufacturer

Cipla USA Inc.

NDC

69097050327

Classification

Generic

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

10/21/2026

Active Ingredients

DIHYDROERGOTAMINE MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212907

FDA Approved

5/20/2020

TE Code

AB

On Market Since

5/23/2020

Pharmacological Classes

Price Statistics

The NADAC for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY has been published 329 times since Jul 29, 2020, and over the history we have for it it has declined 92.0%. The table below summarizes its recorded NADAC range and movement.

Current price$29.3540 per ML
All-time high$365.0048 (Aug 12, 2020)
All-time low$29.3540 (Oct 21, 2026)
52-week high$35.4287
52-week low$29.3540
Median price$111.5162
Average price$98.7749
Largest weekly change+106.2% (Apr 17, 2024)
Weeks tracked329
Tracking sinceJul 29, 2020

Price History

1W

0.0%

1M

-0.3%

3M

-6.9%

6M

-17.1%

1Y

-8.2%

3Y

-14.2%

5Y

-83.2%

All

-92.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dihydroergotamine Mesylate Nasal market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY, manufactured by Cipla USA Inc., is $29.3540 per ML (NDC 69097050327), effective Nov 11, 2026.

How has the price of DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY changed over time?

Over the history we have for it, the NADAC for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY has declined 92.0%. It has been tracked across 329 weekly CMS publications since Jul 29, 2020.

What are the highest and lowest recorded NADAC prices for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?

Since Jul 29, 2020, the NADAC for DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY has ranged from a low of $29.3540 (Oct 21, 2026) to a high of $365.0048 (Aug 12, 2020), with a median of $111.5162 per ML.

Are there cheaper alternatives to DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?

No other NADAC-published product currently shares the active ingredient and strength of DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY?

DIHYDROERGOTAMINE MESYLATE 4 MG/ML NASAL SPRAY (NDC 69097050327) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.